Keyword Connections

parkinson’s disease

Journals

32

1 ACS chemical neuroscience

2 zhurnal nevrologii i psikhiatrii imeni ss korsakova

3 BMC medical informatics and decision making

4 toxicology letters

5 Cells

6 frontiers in aging neuroscience

7 Biomolecules

8 journal of neurosurgery

9 Complementary therapies in medicine

10 brain and language

11 gait & posture

12 advances in experimental medicine and biology

13 Brain

14 Frontiers in neuroscience

15 BMC nursing

16 molecular neurobiology

17 frontiers in molecular neuroscience

18 journal of movement disorders

19 bmc neurology

20 acta neuropsychiatrica

21 Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

22 The Journal of nervous and mental disease

23 Neural regeneration research

24 The International journal of neuroscience

25 interdisciplinary sciences, computational life sciences

26 journal of parkinson's disease

27 Journal of neural transmission (Vienna, Austria : 1996)

28 eurointervention : journal of europcr in collaboration with the working group on interventional cardiology of the european society of cardiology

29 american journal of stem cells

30 journal of critical care medicine (universitatea de medicina si farmacie din targu-mures)

31 ieee journal of translational engineering in health and medicine

32 Clinical parkinsonism & related disorders

Research Groups

0

No Research Group Connected

Bibliographies

189

1 A Fully Automatic Framework for Parkinson's Disease Diagnosis by Multi-Modality Images.

2 Nucleus basalis of Meynert neuronal activity in Parkinson's disease.

3 Monoamine Oxidases (MAOs) as Privileged Molecular Targets in Neuroscience: Research Literature Analysis.

4 Effect of stromal cell-derived factor-1/CXCR4 axis in neural stem cell transplantation for Parkinson's disease.

5 Tai Chi and Parkinson's disease (PD): A systematic overview of the scientific quality of the past systematic reviews.

6 Impact of motor fluctuations on real-life gait in Parkinson's patients.

7 Altered Global Synchronizations in Patients With Parkinson's Disease: A Resting-State fMRI Study.

8 Communication impairment in Parkinson's disease: Impact of motor and cognitive symptoms on speech and language.

9 Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results.

10 COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson's disease.

11 A review of the emerging potential therapy for neurological disorders: human embryonic stem cell therapy.

12 Acupuncture Inhibits the Increase in Alpha-Synuclein in Substantia Nigra in an MPTP- Induced Parkinsonism Mouse Model.

13 Accidental Modopar Poisoning in a Two-Year-Old Child: A Case Report.

14 Impact of orthostatic hypotension on wheelchair use in patients with Parkinson's disease.

15 [Subjective and objective subtypes of excessive daytime sleepiness in Parkinson's disease].

16 Glial cells in intracerebral transplantation for Parkinson's disease.

17 Perceived effects of Tango Argentino on body experience in persons with Parkinson's disease (PD)-A qualitative study with affected persons and their partners.

18 Comparison of Spontaneous Motor Tempo during Finger Tapping, Toe Tapping and Stepping on the Spot in People with and without Parkinson's Disease.

19 Endoplasmic reticulum stress, an important factor in the development of Parkinson's disease.

20 A Network Pharmacology-Based Study of the Molecular Mechanisms of Shaoyao-Gancao Decoction in Treating Parkinson's Disease.

21 Automated Detection of Parkinson's Disease Based on Multiple Types of Sustained Phonations Using Linear Discriminant Analysis and Genetically Optimized Neural Network.

22 Wearable Inertial Sensors to Assess Standing Balance: A Systematic Review

23 How to Select Balance Measures Sensitive to Parkinson’s Disease from Body-Worn Inertial Sensors—Separating the Trees from the Forest

24 Validity of a Fully-Immersive VR-Based Version of the Box and Blocks Test for Upper Limb Function Assessment in Parkinson’s Disease

25 The Impact of a Novel Immersive Virtual Reality Technology Associated with Serious Games in Parkinson’s Disease Patients on Upper Limb Rehabilitation: A Mixed Methods Intervention Study

26 Validity of a Fully-Immersive VR-Based Version of the Box and Blocks Test for Upper Limb Function Assessment in Parkinson’s Disease

27 Reduced Gray Matter Volume and Risk of Falls in Parkinson’s Disease with Dementia Patients: A Voxel-Based Morphometry Study

28 The Impact of a Novel Immersive Virtual Reality Technology Associated with Serious Games in Parkinson’s Disease Patients on Upper Limb Rehabilitation: A Mixed Methods Intervention Study

29 Accurate fall detection for patients with Parkinson's disease based on a data event algorithm and wireless sensor nodes

30 therapeutic potential of a prolyl hydroxylase inhibitor fg-4592 for parkinson’s diseases in vitro and in vivo: regulation of redox biology and mitochondrial function

31 evaluation of rna blood biomarkers in the parkinson’s disease biomarkers program

32 serial dopamine transporter imaging of nigrostriatal function in parkinson’s disease with probable rem sleep behavior disorder

33 gene therapy for the treatment of parkinson’s disease: the nature of the biologics expands the future indications

34 dopaminergic progenitors derived from epiblast stem cells function similarly to primary vm-derived progenitors when transplanted into a parkinson’s disease model

35 the enzymatic core of the parkinson’s disease-associated protein lrrk2 impairs mitochondrial biogenesis in aging yeast

36 identification of circulating micrornas for the differential diagnosis of parkinson’s disease and multiple system atrophy.

37 molecular diagnostics of neurodegenerative disorders

38 phase-dependent modulation as a novel approach for therapeutic brain stimulation

39 dj-1 inhibits α-synuclein aggregation by regulating chaperone-mediated autophagy

40 protein phosphorylation in neurodegeneration: friend or foe?

41 gait and tremor assessment for patients with parkinson’s disease using wearable sensors

42 complementary & alternative management of parkinson’s disease: an evidence-based review of eastern influenced practices

43 abnormal temporal coupling of tactile perception and motor action in parkinson’s disease

44 eye movement control during visual pursuit in parkinson’s disease

45 disrupted nodal and hub organization account for brain network abnormalities in parkinson’s disease

46 p300 wave confirmation in patients with parkinson’s disease

47 caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in parkinson’s disease

48 Αlpha-synuclein as a mediator in the interplay between aging and parkinson’s disease

49 a patient with recurrent dyskinesia and hyperpyrexia syndrome

50 brain-derived neurotrophic factor serum levels correlate with cognitive performance in parkinson’s disease patients with mild cognitive impairment

51 expression analysis of the long non-coding rna antisense to uchl1 (as uchl1) during dopaminergic cells’ differentiation in vitro and in neurochemical models of parkinson’s disease

52 gender differences in age-related striatal dopamine depletion in parkinson’s disease

53 antiparkinsonian efficacy of guanosine in rodent models of movement disorder

54 glucocerebrosidase mutations and synucleinopathies. potential role of sterylglucosides and relevance of studying both gba1 and gba2 genes

55 executive dysfunction in parkinson's disease and timing deficits

56 parkinson’s disease severity at 3 years can be predicted from non-motor symptoms at baseline

57 need for registration and reporting of acupuncture trials in parkinson’s disease in korea

58 alterations of brain structural network in parkinson’s disease with and without rapid eye movement sleep behavior disorder

59 neurochemical systems of the retina involved in the control of movement

60 genetic factors and manganese-induced neurotoxicity

61 Преимущества организации длительной когнитивной реабилитации при болезни Паркинсона в специализированном клинико-диагностическом кабинете

62 neural foundations of action-related language: studies in parkinson’s disease

63 effect of dopaminergic medication on postural sway in advanced parkinson’s disease

64 rescue procedures after suboptimal deep brain stimulation outcomes in common movement disorders

65 compensatory mechanisms in genetic models of neurodegeneration: are the mice better than humans?

66 modulation of alpha-synuclein expression and associated effects by microrna let-7 in transgenic c. elegans

67 self-management in long term conditions using smartphones: a pilot study in parkinson’s disease

68 the influences of age on olfaction: a review

69 what is narrative bioethics

70 cognitive performance patterns in healthy individuals with substantia nigra hyperechogenicity and early parkinson’s disease

71 effects of rhythmic stimulus presentation on oscillatory brain activity: the physiology of cueing in parkinson’s disease

72 long-term monitoring gait analysis using a wearable device in daily lives of patients with parkinson’s disease: the efficacy of selegiline hydrochloride for gait disturbance

73 depression reduces accuracy while parkinsonism slows response time for processing positive feedback in patients with parkinson’s disease with comorbid major depressive disorder tested on a probabilistic category-learning task

74 effects of sensitive electrical stimulation based cueing in parkinson's disease: a preliminary study

75 akinetic crisis in parkinson's disease is associated with a severe loss of striatal dopamine transporter function: a report of two cases

76 α-synuclein alters toll-like receptor expression

77 ninetieth anniversary of parkinson’s disease «substantia nigra» theory

78 investigating emotions in parkinson's disease: what we know and what we still don't know

79 asthenia in patients with chronic neurological diseases

80 Evaluation of the combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents: monoamine oxidase-B inhibition, neuroprotection and oxidative stress modulation.

81 Icaritin Provides Neuroprotection in Parkinson’s Disease by Attenuating Neuroinflammation, Oxidative Stress, and Energy Deficiency

82 Intelligent Sensory Pen for Aiding in the Diagnosis of Parkinson’s Disease from Dynamic Handwriting Analysis

83 Apigenin alleviates neuroinflammation in a mouse model of Parkinson's disease.

84 Activated Microglia in the Early Stage of a Rat Model of Parkinson's Disease: Revealed by PET-MRI Imaging by [F]DPA-714 Targeting TSPO.

85 Optic Tract Involvement in a Patient With Relapsing Polychondritis.

86 Effect of the Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulator Dipraglurant on Motor and Non-Motor Symptoms of Parkinson's Disease.

87 Cholinergic innervation topography in GBA-associated de novo Parkinson's disease patients.

88 GRP78/BIP/HSPA5 as a Therapeutic Target in Models of Parkinson’s Disease: A Mini Review

89 The Swallowing Clinical Assessment Score in Parkinson’s Disease (SCAS-PD) Is a Valid and Low-Cost Tool for Evaluation of Dysphagia: A Gold-Standard Comparison Study

90 Changes of Retina Are Not Involved in the Genesis of Visual Hallucinations in Parkinson’s Disease

91 Biomechanical System Versus Observational Rating Scale for Parkinson’s Disease Tremor Assessment

92 Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages

93 Translational methods to detect asymmetries in temporal and spatial walking metrics in parkinsonian mouse models and human subjects with Parkinson’s disease

94 Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson’s Disease

95 Effectiveness of SaeboReJoyce in the Evaluation of the Improvement of the Occupational Performance in Parkinson’s Disease: An Outcome Research

96 Psychological Benefits of Nonpharmacological Methods Aimed for Improving Balance in Parkinson’s Disease: A Systematic Review

97 Changes in Phonation and Their Relations with Progress of Parkinson’s Disease

98 Centenary of Tretiakoff’s thesis on the morphology of Parkinson’s disease, evolved on the grounds of encephalitis lethargica pathology

99 Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson’s disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation

100 Identifying a glucose metabolic brain pattern in an adeno-associated viral vector based rat model for Parkinson’s disease using <sup>18</sup>F-FDG PET imaging

101 Classification of Patients with Parkinson’s Disease Using Medical Imaging and Artificial Intelligence Algorithms